Insider Transactions in Q1 2022 at Forma Therapeutics Holdings, Inc. (FMTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Jeannette Potts Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.55%
|
-
|
|
Feb 28
2022
|
Brian Andrew Lesser SVP, Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.99%
|
-
|
|
Feb 28
2022
|
Todd Shegog SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,330
+37.25%
|
-
|
|
Feb 28
2022
|
Patrick F. Kelly SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.76%
|
-
|
|
Feb 28
2022
|
John E Bishop SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,950
+35.12%
|
-
|
|
Feb 28
2022
|
David N Cook SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+37.61%
|
-
|
|
Feb 28
2022
|
Frank D. Lee President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
121,667
+37.66%
|
-
|
|
Feb 23
2022
|
Jeannette Potts Officer |
SELL
Open market or private sale
|
Direct |
4,672
-17.28%
|
$42,048
$9.78 P/Share
|
|
Feb 23
2022
|
Mary E. Wadlinger Officer |
SELL
Open market or private sale
|
Direct |
4,684
-3.36%
|
$42,156
$9.78 P/Share
|
|
Feb 23
2022
|
Brian Andrew Lesser SVP, Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,837
-17.9%
|
$34,533
$9.78 P/Share
|
|
Feb 23
2022
|
Todd Shegog SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,687
-19.95%
|
$51,183
$9.78 P/Share
|
|
Feb 23
2022
|
Patrick F. Kelly SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,245
-7.48%
|
$47,205
$9.78 P/Share
|
|
Feb 23
2022
|
Frank D. Lee President and CEO |
SELL
Open market or private sale
|
Direct |
17,981
-18.39%
|
$161,829
$9.78 P/Share
|
|
Feb 23
2022
|
David N Cook SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,531
-17.66%
|
$31,779
$9.78 P/Share
|
|
Jan 12
2022
|
Arturo Md Molina Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+50.0%
|
-
|